BIODESIX, INC. Shareholders' Equity
BIODESIX, INC. (BDSX) had Shareholders' Equity of $9.14 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $9.14M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.13M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$2.46M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$1.72M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $9.14M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $9.13M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | -$2.46M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | -$1.72M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $1.14M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $11.06M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $20.88M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $27.86M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $36.26M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | -$5.50M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $4.58M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$1.45M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | -$6.99M 10-Q · filed 2024-11-01 | |
| 2023-03-31 | $4.55M 10-Q · filed 2024-11-01 | |
| 2022-12-31 | $20.61M 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$2.90M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $7.67M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $7.78M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $19.73M 10-K · filed 2024-03-01 | |
| 2021-09-30 | $16.03M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $25.77M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $36.43M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $41.17M 10-K · filed 2023-03-06 | |
| 2020-09-30 | -$251.78M 10-Q · filed 2021-11-15 | -$255.18M 10-Q · filed 2020-12-10 |
| 2020-06-30 | -$243.04M 10-Q · filed 2021-11-15 | -$246.44M 10-Q · filed 2020-12-10 |
| 2020-03-31 | -$234.83M 10-Q · filed 2021-11-15 | -$238.23M 10-Q · filed 2020-12-10 |
| 2019-12-31 | -$225.14M 10-K · filed 2022-03-14 | -$228.54M 10-Q · filed 2020-12-10 |
| 2019-09-30 | -$222.06M 10-Q · filed 2020-12-10 | |
| 2019-06-30 | -$212.52M 10-Q · filed 2020-12-10 | |
| 2019-03-31 | -$205.71M 10-Q · filed 2020-12-10 | |
| 2018-12-31 | -$194.63M 10-K · filed 2021-03-16 | -$198.03M 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |